Scarica l'app Stockscreener
6.79
4.77%
-0.34
Dopo l'orario di chiusura:
6.98
0.19
+2.80%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.13
Aprire:
$7.15
Volume 24 ore:
1.15M
Relative Volume:
0.81
Capitalizzazione di mercato:
$497.92M
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-2.7714
EPS:
-2.45
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
-2.86%
1M Prestazione:
-2.44%
6M Prestazione:
-26.67%
1 anno Prestazione:
+75.91%
Intervallo 1D:
$6.79
$7.32
Intervallo di 1 settimana:
$6.75
$7.70
Portata 52W:
$3.82
$12.22
Mind Medicine Inc Stock (MNMD) Company Profile
Nome
Mind Medicine Inc
Settore
Industria
Telefono
212-220-6633
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Confronta MNMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
6.79 | 497.92M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Evercore ISI | Outperform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-10-14 | Ripresa | Leerink Partners | Outperform |
| 2024-07-24 | Iniziato | ROTH MKM | Buy |
| 2024-05-29 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-15 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | Canaccord Genuity | Buy |
| 2022-12-09 | Ripresa | ROTH Capital | Buy |
| 2022-11-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-26 | Iniziato | Oppenheimer | Outperform |
| 2022-08-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Iniziato | ROTH Capital | Buy |
| 2021-06-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Mind Medicine Inc Borsa (MNMD) Ultime notizie
HC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Leerink Partnrs Has Bearish Outlook for MNMD Q4 Earnings - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Equities Analysts Set Expectations for MNMD Q1 Earnings - Defense World
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety - TipRanks
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's Why - MarketBeat
What is Leerink Partnrs' Forecast for MNMD Q1 Earnings? - MarketBeat
MindMed launches phase 3 trial for anxiety treatment - Investing.com
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - bastillepost.com
(MNMD) Trading Signals - Stock Traders Daily
MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish - MSN
Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Evercore ISI - MarketBeat
Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - MSN
Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at Evercore ISI - MarketBeat
This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
Why Mind Medicine Stock Is Soaring Today - MSN
Where are the Opportunities in (MNMD) - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4%What's Next? - MarketBeat
Wealth Enhancement Advisory Services LLC Acquires 2,230 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Barclays PLC Has $775,000 Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
MindMed gives more detail to investors in latest presentation - Green Market Report
Psychedelic drug developer Lykos could get lifeline from former Tesla board member - Seeking Alpha
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Mind Medicine Inc Reports Topline Data from Phase 1 Trial of MM-110 in Development for Treatment of Opioid Withdrawal - Marketscreener.com
Institutional investors are Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) biggest bettors and were rewarded after last week's US$73m market cap gain - Simply Wall St
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% HigherShould You Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7%Should You Sell? - MarketBeat
MindMed to Participate in the Jefferies Global Healthcare Conference - Marketscreener.com
Geode Capital Management LLC Has $9.55 Million Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Purchased by Barclays PLC - MarketBeat
(MNMD) Investment Analysis - Stock Traders Daily
Mind Medicine's chief medical officer sells shares worth $49,357 - Investing.com India
Mind Medicine's chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Australia
Mind Medicine CEO Robert Barrow sells shares worth $141,957 By Investing.com - Investing.com Nigeria
Mind Medicine's chief legal officer sells $33,576 in stock - Investing.com India
Mind Medicine CEO Robert Barrow sells shares worth $141,957 - Investing.com India
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $141,957.58 in Stock - MarketBeat
Carrie Liao Sells 2,273 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock - MarketBeat
Mind medicine's chief accounting officer sells shares for $16,888 By Investing.com - Investing.com Canada
Mind Medicine’s chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Nigeria
Mind Medicine's chief legal officer sells $33,576 in stock By Investing.com - Investing.com South Africa
Mind Medicine’s chief legal officer sells $33,576 in stock By Investing.com - Investing.com Nigeria
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 8.5%Here's Why - MarketBeat
Mind Medicine Inc Azioni (MNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):